AG0027I4

183319-69-9 | 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)

AG0027I4

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	183319-69-9
Catalog Number	AG0027I4(AGN-PC-0QCGL0)
Chemical Name	4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
IUPAC Name	N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
InChI	InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H
InChI Key	GTTBEUCJPZQMDZ-UHFFFAOYSA-N
MDL Number	MFCD07781272
Molecular Formula	C22H23ClN3O4
Molecular Weight	429.8967
NSC Number	718781
SMILES	[H+].C1=C(OCCOC)C(=CC2=NC=NC(=C12)NC3=CC(=CC=C3)C#C)OCCOC.[Cl-]
UNII	DA87705X9K
Synonyms	11C erlotinib, 11C-erlotinib, 358,774, CP, 358774, CP, CP 358,774, CP 358774, CP-358,774, CP-358774, CP358,774, CP358774, erlotinib, erlotinib HCl, erlotinib hydrochloride, HCl, Erlotinib, Hydrochloride, Erlotinib, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, OSI 774, OSI-774, OSI774, Tarceva, Erlotinib hydrochloride, 183319-69-9, erlotinib HCl, Tarceva, OSI-774, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride, OSI 774, Erlotinib (Hydrochloride), CP 358774, CP-358774, Erlotinib HCl (OSI-744), UNII-DA87705X9K, DA87705X9K, 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride, MFCD07781272, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1), NSC-718781, 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl, (CP358774, NSC 718781, C22H24ClN3O4, 4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride, [6,7-BIS-(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)-AMINE HYDROCHLORIDE, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride, CHEBI:53509, SMR002529980, NSC718781, RG-1415, 183319-69-9 pound not183321-74-6, AK-75676, Erlotinib HCl salt :Tarceva, R-1415, Erlotinib hydrochloride [USAN], Erlotinib, HCl, erlotinib hcl salt, N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride, Erlotinib hydrochloride [USAN:INN], Tarceva (OSI), tarceva hydrochloride, erlotonib hydrochloride, Erlotinib-Hydrochloride, Erlotinib(OSI-744), AC1L42EJ, erlotinib, hydrochloride salt, MLS003899192, MLS004774139, C22H23N3O4.HCl, BIFK0020, CHEMBL1079742, NSC 718781) HCl, DTXSID10171412, EX-A064, SYN1039, GTTBEUCJPZQMDZ-UHFFFAOYSA-N, Tarceva (Erlotinib Hydrochloride), ZX-AFC000217, BCPP000238, AOB87784, BCP02600, ABP000864, ABP001100, AC-400, RS0032, s1023, AKOS015849087, AN-1331, API0002588, BCP9000658, CS-0123, KS-1202, MCULE-9498970160, PB30965, SB16917, Ro-50-8231, 4CA-0509, BC215798, BP-30224, BR-75676, HY-12008, M375, SC-18020, AB0044024, AB1008594, LS-184396, ST2413548, AM20090622, Erlotinib Hydrochloride/Tarceva,CP-358774, FT-0083537, FT-0651479, CP-35877401, EC-000.2313, CP-358774-01, E-4007, J10200, CP-358,774-01, 319E699, I01-1228, F0001-2385, Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781, 6,7-Bis-(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride, [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride, N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride, N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride, N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride, Erlotinib, HCl, Erlotinib, 11C erlotinib, 11C-erlotinib, erlotinibhydrochloride, Hydrochloride, Erlotinib, OSI774, C22H23N3O4, C22-H23-N3-O4.Cl-H, CID176871, ACN-032357, CS-M-58440, CP358774, CP358,774, 358774, CP, A8234, CP 358,774, CP-358,774, 358,774, CP, A10362, S-2484, Erlotinib hydrochloride, 98.5% - 100MG 100mg, D000069347, 183321-74-6, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, 183321-84-8,

Complexity	525
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	429.146g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	429.901g/mol
Monoisotopic Mass	429.146g/mol
Rotatable Bond Count	11
Topological Polar Surface Area	74.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H315-H319-H335-H412
Packing Group	Ⅲ
Precautionary statements	P261-P273-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number